Product NDC: | 51991-294 |
Proprietary Name: | OXCARBAZEPINE |
Non Proprietary Name: | OXCARBAZEPINE |
Active Ingredient(s): | 600 mg/1 & nbsp; OXCARBAZEPINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51991-294 |
Labeler Name: | Breckenridge Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078069 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080111 |
Package NDC: | 51991-294-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (51991-294-05) |
NDC Code | 51991-294-05 |
Proprietary Name | OXCARBAZEPINE |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (51991-294-05) |
Product NDC | 51991-294 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | OXCARBAZEPINE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20080111 |
Marketing Category Name | ANDA |
Labeler Name | Breckenridge Pharmaceutical, Inc. |
Substance Name | OXCARBAZEPINE |
Strength Number | 600 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |